High prevalence and functional impairment make anxiety disorders a major concern in psychiatric care. With anxiety disorders: advances in therapy and research, new pathways are being explored beyond conventional exposure-based treatments. Advances in neurobiology have revealed how fear circuitry and stress responses can be modulated through therapies such as mindfulness-based interventions, EMDR, and even psychedelic-assisted therapy. Emerging pharmacologic agents offer rapid symptom relief with fewer side effects. Technological tools like virtual reality are enhancing the delivery of exposure therapy, especially for social and phobic anxiety. Combining neuroscience, psychotherapy, and tech-based delivery systems fosters earlier intervention, higher engagement, and sustained treatment outcomes.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Evaluation of prevalence and pattern of tobacco use in yenagoa city in bayelsa state south of nigeria
Owonaro Peter, Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Title : Engaging learners through gamification, creativity, and human-centered design
Tero Moliis, Versantium, United States
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern
Darcy Tocci, NSU College of Pharmacy, United States
Title : Awakening sovereignty within: Healing trauma, releasing codependency, and returning to self-trust
Whitney Walker, Mental Health Therapist/ Podcast Host, United States
Title : You can save a life: Real conversations, real solutions for suicide prevention
frank King, The Mental Health Comedian, LLC, United States